FAERS analysis identified 287,201 adverse events associated with GLP-1RAs, with Ozempic showing 43.9% serious adverse events
These results are shown in tables I, II, and III below: Conclusion Performance gain 7-10 days after treatment #1 was significant (+2.1%) with total performance gains from intravenous glutathione +7.2% over 36 days (57:30 to 52:21 minutes:seconds), averaging a remarkable +1.8% per treatment administered
L-Glutathione injections are generally well tolerated, but some people may experience mild side effects such as injection site pain, redness, swelling, or irritation
Increased numbers of mast cells are in the skin, respiratory tract, and digestive tract
Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance